STOCK TITAN

Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Enovis™ (NYSE: ENOV), a medical technology company, is set to unveil its new Tarsoplasty Percutaneous Lapidus System and offer live demonstrations of Better Step, a patient-focused platform, at the American Orthopaedic Foot & Ankle Society® (AOFAS) annual meeting from September 11–14, 2024, in Vancouver. The Tarsoplasty system aims to reduce operative time and improve patient recovery outcomes for bunionectomy procedures. Better Step enhances the patient experience throughout bunion surgery recovery. Enovis will also showcase other advanced solutions, including the DynaNail® TTC Fusion System, Evolve34™ Lapidus Correction System, and expanded options for the Arsenal Foot Plating System.

Enovis™ (NYSE: ENOV), un'azienda di tecnologia medica, sta per presentare il suo nuovo Sistema Lapidus Percutaneo per Tarsoplastica e offrirà dimostrazioni dal vivo di Better Step, una piattaforma incentrata sul paziente, durante il meeting annuale della Società Americana di Ortopedia del Piede e della Caviglia® (AOFAS) che si terrà dal 11 al 14 settembre 2024 a Vancouver. Il sistema di Tarsoplastica mira a ridurre i tempi operatori e migliorare i risultati del recupero dei pazienti nelle procedure di bionectomia. Better Step migliora l'esperienza del paziente durante il recupero dalla chirurgia del piede. Enovis presenterà anche altre soluzioni avanzate, tra cui il DynaNail® TTC Fusion System, il Sistema di Correzione Lapidus Evolve34™ e opzioni ampliate per il Sistema di Placcatura Arsenal per il Piede.

Enovis™ (NYSE: ENOV), una empresa de tecnología médica, está lista para presentar su nuevo Sistema Lapidus Percutáneo para Tarsoplastia y ofrecer demostraciones en vivo de Better Step, una plataforma centrada en el paciente, en la reunión anual de la Sociedad Americana de Ortopedia del Pie y Tobillo® (AOFAS) del 11 al 14 de septiembre de 2024 en Vancouver. El sistema de Tarsoplastia tiene como objetivo reducir el tiempo quirúrgico y mejorar los resultados de recuperación del paciente en procedimientos de bunionectomía. Better Step mejora la experiencia del paciente durante la recuperación de la cirugía de juanetes. Enovis también mostrará otras soluciones avanzadas, incluyendo el DynaNail® TTC Fusion System, el Sistema de Corrección Lapidus Evolve34™ y opciones ampliadas para el Sistema de Placas Arsenal para el Pie.

Enovis™ (NYSE: ENOV)는 새로운 경과성 라피두스 시스템을 발표하고, Better Step라는 환자 중심 플랫폼의 라이브 데모를 제공할 예정입니다. 이 행사는 2024년 9월 11일부터 14일까지 밴쿠버에서 열리는 미국 정형외과 발과 발목 학회® (AOFAS) 연례 회의에서 진행됩니다. Tarsoplasty 시스템은 수술 시간을 단축하고 환자의 회복 결과를 개선하는 것을 목표로 하며, Better Step은 환자의 수술 후 회복 경험을 강화합니다. Enovis는 또한 DynaNail® TTC Fusion System, Evolve34™ Lapidus Correction SystemArsenal Foot Plating System의 확장된 옵션을 포함하여 다른 첨단 솔루션을 선보일 예정입니다.

Enovis™ (NYSE: ENOV), une entreprise de technologie médicale, s'apprête à dévoiler son nouveau Système de Tarsoplastie Percutanée de Lapidus et proposera des démonstrations en direct de Better Step, une plateforme axée sur le patient, lors de la réunion annuelle de la Société Américaine d'Orthopédie du Pied et de la Cheville® (AOFAS), qui se déroulera du 11 au 14 septembre 2024 à Vancouver. Le système de Tarsoplastie vise à réduire le temps opératoire et à améliorer les résultats de récupération pour les procédures de bionectomie. Better Step améliore l'expérience du patient durant la récupération après une chirurgie des oignons. Enovis présentera également d'autres solutions avancées, y compris le DynaNail® TTC Fusion System, le Système de Correction Lapidus Evolve34™ et des options élargies pour le Système de Plaquage Arsenal pour le Pied.

Enovis™ (NYSE: ENOV), ein Medizintechnikunternehmen, wird sein neues Perkutanes Lapidus-Tarsoplastik-System vorstellen und vor Ort Live-Demonstrationen der patientenorientierten Plattform Better Step anbieten, die während des Jahrestreffens der American Orthopaedic Foot & Ankle Society® (AOFAS) vom 11. bis 14. September 2024 in Vancouver stattfinden wird. Das Tarsoplastik-System zielt darauf ab, die Operationszeit zu verkürzen und die Genesungsergebnisse für Patienten bei Bunion-Operationen zu verbessern. Better Step verbessert das Patientenerlebnis während der Genesung von der Bunion-Chirurgie. Enovis wird auch andere fortschrittliche Lösungen präsentieren, darunter das DynaNail® TTC Fusion System, das Evolve34™ Lapidus Correction System und erweiterte Optionen für das Arsenal Foot Plating System.

Positive
  • Introduction of innovative Tarsoplasty Percutaneous Lapidus System for improved bunionectomy procedures
  • Launch of Better Step patient-focused platform to enhance patient experience during recovery
  • Expansion of product portfolio with advanced foot and ankle solutions
  • Showcasing products at major industry event (AOFAS annual meeting) to increase visibility
Negative
  • None.

With the upcoming launch of the innovative Tarsoplasty solution and live demonstrations of the Better Step patient-focused platform, Enovis™ Foot & Ankle continues to drive its portfolio into “The Fast Lane.”

Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus System and offer live demonstrations of Better Step, a patient-focused platform, alongside other advanced product offerings at the American Orthopaedic Foot & Ankle Society® (AOFAS) annual meeting in Vancouver, British Columbia from September 11–14, 2024.

 “Our expanding portfolio continues to deliver solutions that drive better patient outcomes and surgical efficiency,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “This year, we’re reinforcing that Enovis is not just keeping pace with the rapidly evolving foot and ankle landscape—we’re driving it into the fast lane.”

At the meeting, Enovis will unveil the Tarsoplasty Percutaneous Lapidus System, an innovative approach to the Lapidus bunionectomy that features next generation instruments and implants for a more guided, reproducible percutaneous procedure—enabling surgeons to reduce operative time and improve recovery outcomes for patients.

“The clinical data supporting the Tarsoplasty System highlights the effectiveness of the percutaneous approach to hallux valgus correction,” stated Shannon Cummings, Global Vice President of Marketing for Enovis Foot & Ankle. “We’re confident that this system will showcase our expertise in percutaneous foot and ankle surgery and our dedication to enhancing these procedures broadly.”

In addition to the Tarsoplasty System, Enovis will offer live demonstrations of Better Step, a patient-focused platform designed to enhance the patient experience throughout the bunion surgery journey. The app encourages physicians to deliver personalized care through custom videos, educational materials, and recovery protocols tailored to each patient’s needs.

“We are thrilled to showcase Tarsoplasty and Better Step at AOFAS,” said Justak. “These offerings exemplify our commitment to empowering surgeons and enabling patients to take an active role in their recovery journey.”

The company will also showcase an array of advanced solutions from its comprehensive foot and ankle continuum, including:

AOFAS attendees have opportunities throughout the week to experience these product offerings firsthand.

  • Visit Enovis booth #104 in the exhibit hall.
  • Educational presentations from Drs. Samuel Adams and Christopher Gross on demand virtually, “The Use of Highly Variable Angle Screws increased Compression in Orthopaedic Plating” and in-person on Sept. 12 at 1:30 PM: “Biomechanical Advantages of sustained Dynamic compression over static Fixation in Subtalar Arthrodesis.

About Enovis

Enovis™ (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

Media Contacts

Diana Aldermae, Enovis™ Foot & Ankle

Diana.Aldermae@enovis.com

Leda Buster, Enovis™ Bracing & Supports

Leda.Buster@enovis.com


Attachment


FAQ

What new product is Enovis (ENOV) introducing at the AOFAS 2024 annual meeting?

Enovis is introducing the Tarsoplasty Percutaneous Lapidus System, an innovative approach to Lapidus bunionectomy, at the AOFAS 2024 annual meeting.

When and where is Enovis (ENOV) showcasing its new foot and ankle surgery offerings?

Enovis is showcasing its new foot and ankle surgery offerings at the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting in Vancouver, British Columbia from September 11–14, 2024.

What is the Better Step platform being demonstrated by Enovis (ENOV)?

Better Step is a patient-focused platform designed to enhance the patient experience throughout the bunion surgery journey, offering personalized care through custom videos, educational materials, and recovery protocols.

What are some other products Enovis (ENOV) will showcase at the AOFAS 2024 meeting?

Enovis will showcase products including the DynaNail® TTC Fusion System, Evolve34™ Lapidus Correction System, Arsenal Foot Plating System, Tiger Cannulated Screw System, DonJoy® Velocity® + Ankle Brace, and Aircast AirSelect Elite Pneumatic Walking Boot.

Enovis Corporation

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Stock Data

2.39B
55.33M
0.95%
110.96%
7.91%
Specialty Industrial Machinery
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
WILMINGTON